BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19507150)

  • 21. Cell microarrays and RNA interference chip away at gene function.
    Wheeler DB; Carpenter AE; Sabatini DM
    Nat Genet; 2005 Jun; 37 Suppl():S25-30. PubMed ID: 15920526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens.
    Perrimon N; Friedman A; Mathey-Prevot B; Eggert US
    Drug Discov Today; 2007 Jan; 12(1-2):28-33. PubMed ID: 17198970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparisons of RNAi approaches for validation of human RNA helicase A as an essential factor in hepatitis C virus replication.
    He QS; Tang H; Zhang J; Truong K; Wong-Staal F; Zhou D
    J Virol Methods; 2008 Dec; 154(1-2):216-9. PubMed ID: 18782589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using RNAi screening technologies to interrogate the extrinsic apoptosis pathway.
    Stephan JP
    Methods Enzymol; 2014; 544():129-60. PubMed ID: 24974289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for host proteins with pro- and antiviral activity using high-throughput RNAi.
    Griffiths SJ
    Methods Mol Biol; 2013; 1064():71-90. PubMed ID: 23996250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput RNAi screen in Drosophila.
    DasGupta R; Gonsalves FC
    Methods Mol Biol; 2008; 469():163-84. PubMed ID: 19109710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA interference: roles in fungal biology.
    Nakayashiki H; Nguyen QB
    Curr Opin Microbiol; 2008 Dec; 11(6):494-502. PubMed ID: 18955156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic approaches to understanding bacterial virulence.
    Burrack LS; Higgins DE
    Curr Opin Microbiol; 2007 Feb; 10(1):4-9. PubMed ID: 17161645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNAi screening: new approaches, understandings, and organisms.
    Mohr SE; Perrimon N
    Wiley Interdiscip Rev RNA; 2012; 3(2):145-58. PubMed ID: 21953743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infectious disease in the genomic era.
    Yang X; Yang H; Zhou G; Zhao GP
    Annu Rev Genomics Hum Genet; 2008; 9():21-48. PubMed ID: 18767959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The second century of Campylobacter research: recent advances, new opportunities and old problems.
    Dorrell N; Wren BW
    Curr Opin Infect Dis; 2007 Oct; 20(5):514-8. PubMed ID: 17762786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A probability-based approach for the analysis of large-scale RNAi screens.
    König R; Chiang CY; Tu BP; Yan SF; DeJesus PD; Romero A; Bergauer T; Orth A; Krueger U; Zhou Y; Chanda SK
    Nat Methods; 2007 Oct; 4(10):847-9. PubMed ID: 17828270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microfluidic platforms for RNA interference screening of virus-host interactions.
    Schudel BR; Harmon B; Abhyankar VV; Pruitt BW; Negrete OA; Singh AK
    Lab Chip; 2013 Mar; 13(5):811-7. PubMed ID: 23361404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Error rates and powers in genome-scale RNAi screens.
    Zhang XD; Marine SD; Ferrer M
    J Biomol Screen; 2009 Mar; 14(3):230-8. PubMed ID: 19211781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic RNA interference for neurodegenerative diseases].
    González-Alegre P
    Rev Neurol; 2008 Dec 16-31; 47(12):641-7. PubMed ID: 19085881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-content siRNA screening.
    Krausz E
    Mol Biosyst; 2007 Apr; 3(4):232-40. PubMed ID: 17372651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population genetics of fungal and oomycete effectors involved in gene-for-gene interactions.
    Stukenbrock EH; McDonald BA
    Mol Plant Microbe Interact; 2009 Apr; 22(4):371-80. PubMed ID: 19271952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNAi screening for host factors involved in viral infection using Drosophila cells.
    Cherry S
    Methods Mol Biol; 2011; 721():375-82. PubMed ID: 21431698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. siRNAs: their potential as therapeutic agents--Part I. Designing of siRNAs.
    Hajeri PB; Singh SK
    Drug Discov Today; 2009 Sep; 14(17-18):851-8. PubMed ID: 19540928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional gene discovery using RNA interference-based genomic screens to combat pathogen infection.
    Hong-Geller E; Micheva-Viteva SN
    Curr Drug Discov Technol; 2010 Jun; 7(2):86-94. PubMed ID: 20836760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.